Pioneering access to complex generic productsÂ
Drug Discovery World
AUGUST 22, 2023
In many cases, it is also challenging to apply traditional bioequivalence methods or to ensure clarity about the comparison model (in-vitro/in-vivo) needed to gain health authority approval. Also, sometimes traditional bioequivalence approaches will not be possible and investment in expensive clinical trials are warranted.
52 
Let's personalize your content